(Q40140463)

English

Ferroquine and artesunate in African adults and children with Plasmodium falciparum malaria: a phase 2, multicentre, randomised, double-blind, dose-ranging, non-inferiority study

scientific article published on 2 September 2015

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

17 September 2017

Ferroquine and artesunate in African adults and children with Plasmodium falciparum malaria: a phase 2, multicentre, randomised, double-blind, dose-ranging, non-inferiority study (English)

1 reference

Europe PubMed Central

17 September 2017

multicenter clinical trial

0 references

Plasmodium falciparum

0 references

0 references

0 references

Plasmodium falciparum malaria

1 reference

based on heuristic

inferred from title

object named as

Ali Sié

8

0 references

object named as

Halidou Tinto

4

0 references

Peter Gottfried Kremsner

26

object named as

Peter G Kremsner

1 reference

Europe PubMed Central

17 September 2017

Benjamin Mordmüller

23

object named as

Benjamin Mordmüller

1 reference

Europe PubMed Central

17 September 2017

25

object named as

Bertrand Lell

1 reference

Europe PubMed Central

17 September 2017

Sodiomon B Sirima

10

object named as

Sodiomon B Sirima

1 reference

Europe PubMed Central

17 September 2017

Maryvonne Kombila

17

object named as

Maryvonne Kombila

1 reference

Europe PubMed Central

17 September 2017

1

object named as

Jana Held

1 reference

Europe PubMed Central

17 September 2017

Marielle Karine Bouyou Akotet

16

object named as

Marielle Bouyou-Akotet

1 reference

Europe PubMed Central

17 September 2017

author name string

Christian Supan

2

1 reference

Europe PubMed Central

17 September 2017

Carmen L O Salazar

3

1 reference

Europe PubMed Central

17 September 2017

Léa N Bonkian

5

1 reference

Europe PubMed Central

17 September 2017

Alain Nahum

6

1 reference

Europe PubMed Central

17 September 2017

Bancole Moulero

7

1 reference

Europe PubMed Central

17 September 2017

Boubacar Coulibaly

9

1 reference

Europe PubMed Central

17 September 2017

Mohamadou Siribie

11

1 reference

Europe PubMed Central

17 September 2017

Nekoye Otsyula

12

1 reference

Europe PubMed Central

17 September 2017

Lucas Otieno

13

1 reference

Europe PubMed Central

17 September 2017

Ahmed M Abdallah

14

1 reference

Europe PubMed Central

17 September 2017

Robert Kimutai

15

1 reference

Europe PubMed Central

17 September 2017

Kimiko Koiwai

18

1 reference

Europe PubMed Central

17 September 2017

Cathy Cantalloube

19

1 reference

Europe PubMed Central

17 September 2017

Chantal Din-Bell

20

1 reference

Europe PubMed Central

17 September 2017

Elhadj Djeriou

21

1 reference

Europe PubMed Central

17 September 2017

John Waitumbi

22

1 reference

Europe PubMed Central

17 September 2017

Daniel Ter-Minassian

24

1 reference

Europe PubMed Central

17 September 2017

publication date

2 September 2015

1 reference

Europe PubMed Central

17 September 2017

number of pages

11

1 reference

based on heuristic

inferred from page(s)

Lancet Infectious Diseases

1 reference

Europe PubMed Central

17 September 2017

15

1 reference

Europe PubMed Central

17 September 2017

12

1 reference

Europe PubMed Central

17 September 2017

1409-1419

1 reference

Europe PubMed Central

17 September 2017

Antimalarial combinations

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900079-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Short-course artesunate treatment of uncomplicated Plasmodium falciparum malaria in Gabon

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900079-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Evidence of Artemisinin-Resistant Malaria in Western Cambodia

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900079-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Spread of artemisinin resistance in malaria.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900079-1

7 January 2021

based on heuristic

inferred from DOI database lookup

The antimalarial ferroquine: from bench to clinic

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900079-1

7 January 2021

based on heuristic

inferred from DOI database lookup

In vitro activity of ferroquine (SSR 97193) against Plasmodium falciparum isolates from the Thai-Burmese border

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900079-1

7 January 2021

based on heuristic

inferred from DOI database lookup

In vitro susceptibility to a new antimalarial organometallic analogue, ferroquine, of Plasmodium falciparum isolates from the Haut-Ogooué region of Gabon

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900079-1

7 January 2021

based on heuristic

inferred from DOI database lookup

In vitro activity of ferroquine (SAR97193) is independent of chloroquine resistance in Plasmodium falciparum.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900079-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Synthesis and antimalarial activity in vitro and in vivo of a new ferrocene-chloroquine analogue.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900079-1

7 January 2021

based on heuristic

inferred from DOI database lookup

In vitro and in vivo antimalarial activity of ferrochloroquine, a ferrocenyl analogue of chloroquine against chloroquine-resistant malaria parasites

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900079-1

7 January 2021

based on heuristic

inferred from DOI database lookup

In vitro metabolism of ferroquine (SSR97193) in animal and human hepatic models and antimalarial activity of major metabolites on Plasmodium falciparum.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900079-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I randomized dose-ascending placebo-controlled trials of ferroquine--a candidate anti-malarial drug--in adults with asymptomatic Plasmodium falciparum infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900079-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacokinetics of ferroquine, a novel 4-aminoquinoline, in asymptomatic carriers of Plasmodium falciparum infections

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900079-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and safety of dihydroartemisinin-piperaquine for treatment of uncomplicated Plasmodium falciparum malaria in endemic countries: meta-analysis of randomised controlled studies

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900079-1

7 January 2021

based on heuristic

inferred from DOI database lookup

A head-to-head comparison of four artemisinin-based combinations for treating uncomplicated malaria in African children: a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900079-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Malarial parasites vs. antimalarials: never-ending rumble in the jungle

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900079-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Absence of time-dependent artesunate pharmacokinetics in healthy subjects during 5-day oral administration

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900079-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Anti-folate drug resistance in Africa: meta-analysis of reported dihydrofolate reductase (dhfr) and dihydropteroate synthase (dhps) mutant genotype frequencies in African Plasmodium falciparum parasite populations

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900079-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Piperaquine: a resurgent antimalarial drug.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900079-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Ex vivo drug susceptibility of ferroquine against chloroquine-resistant isolates of Plasmodium falciparum and P. vivax

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900079-1

7 January 2021

based on heuristic

inferred from DOI database lookup

In vitro activities of ferrochloroquine against 55 Senegalese isolates of Plasmodium falciparum in comparison with those of standard antimalarial drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900079-1

7 January 2021

based on heuristic

inferred from DOI database lookup

In vitro activity of ferroquine is independent of polymorphisms in transport protein genes implicated in quinoline resistance in Plasmodium falciparum

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900079-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Reassessment of the resistance of Plasmodium falciparum to chloroquine in Gabon: implications for the validity of tests in vitro vs. in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900079-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Medical need, scientific opportunity and the drive for antimalarial drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900079-1

7 January 2021

based on heuristic

inferred from DOI database lookup

A thirteen-year analysis of Plasmodium falciparum populations reveals high conservation of the mutant pfcrt haplotype despite the withdrawal of chloroquine from national treatment guidelines in Gabon

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900079-1

7 January 2021

based on heuristic

inferred from DOI database lookup

How much fat is necessary to optimize lumefantrine oral bioavailability?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900079-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of a high-fat meal on the relative oral bioavailability of piperaquine

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900079-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Cardiotoxicity of antimalarial drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900079-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Electrocardiographic study in Ghanaian children with uncomplicated malaria, treated with artesunate-amodiaquine or artemether-lumefantrine

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900079-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of coadministered fat on the tolerability, safety, and pharmacokinetic properties of dihydroartemisinin-piperaquine in Papua New Guinean children with uncomplicated malaria.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900079-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Antimalarial compounds in Phase II clinical development.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2900079-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1473-3099(15)00079-1

1 reference

Europe PubMed Central

17 September 2017

release_beeznt7nhzez5fj76oqko5hpla

1 reference

https://api.fatcat.wiki/v0/release/beeznt7nhzez5fj76oqko5hpla

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

17 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40140463&oldid=2044483166"